Leuplin and condition aggravated Patient Reports February 11, 2012

Leuplin Side Effects Report #5491362-5
Leuplin side effect was reported by a Physician from JAPAN on Oct 11, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplin. After drug was administered, patient experienced the following side effects: condition aggravated, metastases to central nervous system, metastases to lung, prostate cancer stage iv. Leuplin dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient died.

Leuplin Side Effects Report #5133029-9
Leuplin side effect was reported by a Health Professional from JAPAN on Oct 13, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer  and was treated with Leuplin. After drug was administered, patient experienced the following side effects: blood potassium increased, condition aggravated, contusion, dehydration, haematuria, haemodialysis, hypotension, interstitial lung disease, proteinuria. Leuplin dosage: 11.25 MG (11.25 MG,1 IN 12 WK). During the same period patient was treated with CASODEX, MARZULENE S, THEOLONG, LASIX. Patient died.